RJA
GRX

Raymond James & Associates’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Raymond James & Associates’s Portfolio GRX Stock Details GRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$184K Sell
16,843
-101
-0.6% -$1.06K ﹤0.01% 3669
2024
Q2 		$162K Buy
16,944
+10
+0.1% +$96 ﹤0.01% 3657
2024
Q1 		$173K Sell
16,934
-14
-0.1% -$137 ﹤0.01% 3649
2023
Q4 		$158K Sell
16,948
-492
-3% -$4.23K ﹤0.01% 3567
2023
Q3 		$150K Buy
17,440
+12
+0.1% +$115 ﹤0.01% 3522
2023
Q2 		$174K Sell
17,428
-3,707
-18% -$37.1K ﹤0.01% 3516
2023
Q1 		$213K Sell
21,135
-10,581
-33% -$108K ﹤0.01% 3460
2022
Q4 		$326K Sell
31,716
-2,863
-8% -$28.8K ﹤0.01% 3163
2022
Q3 		$329K Buy
34,579
+331
+1% +$3.69K ﹤0.01% 3123
2022
Q2 		$367K Sell
34,248
-75,660
-69% -$877K ﹤0.01% 3097
2022
Q1 		$1.41M Sell
109,908
-33,795
-24% -$431K ﹤0.01% 2374
2021
Q4 		$1.95M Sell
143,703
-3,311
-2% -$43.9K ﹤0.01% 2195
2021
Q3 		$1.94M Sell
147,014
-144
-0.1% -$1.95K ﹤0.01% 2126
2021
Q2 		$1.99M Buy
147,158
+3,467
+2% +$45.5K ﹤0.01% 2101
2021
Q1 		$1.79M Sell
143,691
-15,200
-10% -$187K ﹤0.01% 2091
2020
Q4 		$1.9M Sell
158,891
-4,454
-3% -$49.4K ﹤0.01% 1914
2020
Q3 		$1.69M Sell
163,345
-13,097
-7% -$137K ﹤0.01% 1865
2020
Q2 		$1.77M Buy
176,442
+2,640
+2% +$26.2K ﹤0.01% 1807
2020
Q1 		$1.5M Buy
173,802
+69,659
+67% +$738K ﹤0.01% 1738
2019
Q4 		$1.2M Sell
104,143
-30,234
-22% -$326K ﹤0.01% 2159
2019
Q3 		$1.4M Sell
134,377
-1,299
-1% -$13.7K ﹤0.01% 1983
2019
Q2 		$1.43M Sell
135,676
-58,476
-30% -$613K ﹤0.01% 2002
2019
Q1 		$2.04M Sell
194,152
-9,618
-5% -$97.2K ﹤0.01% 1753
2018
Q4 		$1.89M Sell
203,770
-58,875
-22% -$605K ﹤0.01% 1695
2018
Q3 		$2.89M Buy
262,645
+46,480
+22% +$494K ﹤0.01% 1574
2018
Q2 		$2.17M Buy
216,165
+18,380
+9% +$179K ﹤0.01% 1712
2018
Q1 		$1.88M Sell
197,785
-12,354
-6% -$125K ﹤0.01% 1742
2017
Q4 		$2.17M Sell
210,139
-102,024
-33% -$1.02M ﹤0.01% 1637
2017
Q3 		$3.16M Sell
312,163
-13,839
-4% -$144K 0.01% 1331
2017
Q2 		$3.54M Sell
326,002
-30,055
-8% -$313K 0.01% 1214
2017
Q1 		$3.56M Sell
356,057
-11,726
-3% -$116K 0.01% 1192
2016
Q4 		$3.47M Sell
367,783
-36,449
-9% -$355K 0.01% 1171
2016
Q3 		$4.21M Sell
404,232
-9,925
-2% -$108K 0.01% 1040
2016
Q2 		$4.42M Sell
414,157
-5,472
-1% -$56.3K 0.01% 917
2016
Q1 		$4.14M Buy
419,629
+8,265
+2% +$79K 0.01% 909
2015
Q4 		$4.22M Sell
411,364
-10,648
-3% -$108K 0.02% 884
2015
Q3 		$4.09M Sell
422,012
-65,219
-13% -$710K 0.02% 842
2015
Q2 		$5.48M Sell
487,231
-5,477
-1% -$61.7K 0.02% 768
2015
Q1 		$5.55M Sell
492,708
-13,883
-3% -$150K 0.02% 693
2014
Q4 		$5.28M Sell
506,591
-644
-0.1% -$6.56K 0.03% 658
2014
Q3 		$5.03M Buy
507,235
+48,154
+10% +$487K 0.03% 631
2014
Q2 		$4.74M Buy
459,081
+9,349
+2% +$94.2K 0.03% 660
2014
Q1 		$4.49M Buy
449,732
+329,084
+273% +$3.29M 0.03% 621
2013
Q4 		$1.21M Buy
120,648
+44,632
+59% +$443K 0.01% 1213
2013
Q3 		$753K Buy
76,016
+53,238
+234% +$518K 0.01% 1395
2013
Q2 		$216K Buy
+22,778
New +$227K ﹤0.01% 1828

Other funds holding GRX

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Raymond James & Associates's GRX Position: Q3 2024 in Review

Raymond James & Associates reduced its Gabelli Healthcare & Wellness Trust (GRX) stake by 0.6% in Q3 2024, selling an estimated $1.06K and leaving 16,843 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3669.

Raymond James & Associates first reported a position in GRX in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.55M in Q1 2015. 67 funds tracked by Wall St. Rank hold GRX as of Q3 2024.

  • Raymond James & Associates held 16,843 shares of Gabelli Healthcare & Wellness Trust worth $184K as of Q3 2024.
  • Raymond James & Associates sold 101 Gabelli Healthcare & Wellness Trust shares in Q3 2024, an estimated $1.06K.
  • Gabelli Healthcare & Wellness Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3669 holding.
  • Raymond James & Associates first reported a position in Gabelli Healthcare & Wellness Trust in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Gabelli Healthcare & Wellness Trust position peaked at $5.55M in Q1 2015.
  • 67 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.